Anterior lenticular opacities in Costello Syndrome [PDF]
Purpose: A case of anterior lenticular opacities in a patient of Costello Syndrome is reported. Observations: Bilateral anterior capsular plaque along with anterior lens opacities (Anterior Segment Optical Coherence Tomography) has been demonstrated in a
Anchal Thakur +5 more
doaj +2 more sources
Fatal leukodystrophy in Costello syndrome: a case report [PDF]
Background Costello syndrome (CS) is a rare genetic condition characterized by dysregulation of the signaling pathway, phenotypic alteration due to fetal macrosomia or growth retardation, facial abnormalities, loose skin, cardiovascular abnormalities ...
Virgilio E. Failoc-Rojas +3 more
doaj +2 more sources
Multidisciplinary Management of Costello Syndrome: Current Perspectives [PDF]
Chiara Leoni,1 Germana Viscogliosi,1 Marco Tartaglia,2 Yoko Aoki,3 Giuseppe Zampino1,4 1Center for Rare Diseases and Birth Defects, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario “A.
Leoni C +4 more
doaj +2 more sources
Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model [PDF]
RAS GTPases are ubiquitous GDP/GTP-binding proteins that function as molecular switches in cellular signalling and control numerous signalling pathways and biological processes.
Sayantan Nandi +8 more
doaj +2 more sources
Dysplastic Mitral Valve in Costello Syndrome [PDF]
Costello syndrome is an autosomal dominant condition caused by variants in the HRAS gene. Cardiac presentation includes valvular disease (usually valvar pulmonary stenosis), arrhythmias, and hypertrophic cardiomyopathy.
Tamara Naneishvili, MBBS +4 more
doaj +2 more sources
Treatment of Dystonia Using Trihexyphenidyl in Costello Syndrome [PDF]
Costello syndrome (CS), a rare syndrome with multisystemic involvement inherited as a dominant trait, is characterized by developmental delay, coarse facial appearance, cardiac defects including hypertrophic cardiomyopathy, skin abnormalities, brain ...
Domenico M. Romeo +7 more
doaj +2 more sources
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model [PDF]
Costello syndrome (CS) is a congenital disorder caused by heterozygous activating germline HRAS mutations in the canonical Ras/mitogen-activated protein kinase (Ras/MAPK) pathway.
William E. Tidyman +4 more
doaj +2 more sources
Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review [PDF]
Background Costello syndrome (CS, OMIM 218040) is a rare congenital disorder caused by mutations in HRAS. Previous studies reported that approximately 80% of patients with CS share the same pathogenic variant in HRAS gene in c.34G> A (p.G12S).
Wen Qian +8 more
doaj +2 more sources
Rapid Weight Loss and Severe Failure to Thrive Mimicking Lipodystrophy Syndrome in a 1-Year-Old Taiwanese Girl with Costello Syndrome [PDF]
Costello syndrome (CS) is a type of RASopathy caused mainly by de-novo heterozygous pathogenic variants in the HRAS gene located on chromosome 11p15.5.
Yu-Min Syu +8 more
doaj +2 more sources
Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status [PDF]
Background Costello syndrome (CS) and cardio-facio-cutaneous syndrome (CFCS) belong to the RASopathies, a group of neurodevelopmental disorders with skeletal anomalies.
Chiara Leoni +11 more
doaj +2 more sources

